Skip to main content

Advertisement

Log in

Vitamin D status in Egyptian patients with juvenile-onset systemic lupus erythematosus

  • Original Article - Observational Research
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

There are scanty data on the prevalence of vitamin D deficiency and its relation to disease activity among patients with juvenile-onset systemic lupus erythematosus (JoSLE) in the Middle East and North Africa, an area known to be endemic for vitamin D deficiency and insufficiency. The aim of this study was, therefore, to study vitamin D status and its relation to disease activity and parameters in Egyptian patients with JoSLE. Serum levels of 25(OH) D3 in 70 JoSLE patients were compared to 40 age-, sex-, and body mass index-matched healthy controls. The 25(OH) D3 was determined by enzyme-linked immunosorbent assay. Information regarding the medical history, clinical symptoms, and signs was registered at the time of serum sampling. Disease activity of SLE was evaluated according to the SLEDAI score. The mean level of serum 25(OH) D3 was 12 ± 3.7 in JoSLE patients compared to 21 ± 3.5 ng/mL in normal controls (p < 0.001). Forty percent (28/70) of the JoSLE patients has severe 25(OH) D3 deficiency (≤10 ng/mL), and 60 % of the JoSLE patients has 25(OH) D3 insufficiency (≤30 ng/mL). None of the JoSLE patients has 25(OH) D3 level >30 ng/mL. There was no significant correlation between serum levels of 25(OH) D3 and the demographic data, medication used, and some laboratory data of patients with JoSLE. Disease activity score in our patients was insignificantly correlated with serum levels of 25(OH) D3. In spite of vitamin D supplementation in Egyptian JoSLE patients and the presence of vitamin D insufficiency in the control group, there are still significantly lower levels of vitamin D in JoSLE compared to normal controls.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Mahon BD, Wittke A, Weaver V, Cantorna MT (2003) The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem 89:922–932

    Article  CAS  PubMed  Google Scholar 

  2. Veldman CM, Cantorna MT, DeLuca HF (2000) Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys 374:334–338

    Article  CAS  PubMed  Google Scholar 

  3. Bhalla AK, Amento EP, Serog B, Glimcher LH (1984) 1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation. J Immunol 133:1748–1754

    CAS  PubMed  Google Scholar 

  4. Mattner F, Smiroldo S, Galbiati F et al (2000) Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D(3). Eur J Immunol 30:498–508

    Article  CAS  PubMed  Google Scholar 

  5. Lemire JM, Archer DC, Beck L, Spiegelberg HL (1995) Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions. J Nutr 125(Suppl 6):1704S–1708S

    CAS  PubMed  Google Scholar 

  6. Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, O’Garra A (2001) 1Alpha,25-dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol 167:4974–4980

    Article  CAS  PubMed  Google Scholar 

  7. Overbergh L, Decallonne B, Waer M, Rutgeerts O, Valckx D (2000) 1alpha,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543). Diabetes 49:1301–1307

    Article  CAS  PubMed  Google Scholar 

  8. Lemire JM, Adams JS, Sakai R, Jordan SC (1984) 1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Investig 74:657–661

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. Griffin MD, Lutz W, Phan VA, Bachman LA, McKean DJ, Kumar R (2001) Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci USA 98:6800–6805

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  10. Penna G, Adorini L (2000) 1 Alpha, 25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 64:2405–2411

    Article  Google Scholar 

  11. Holick MF (2007) Vitamin D deficiency. N Engl J Med 357:266–281

    Article  CAS  PubMed  Google Scholar 

  12. Woodhouse NYJ, Norton WL (1982) Low vitamin D level in Saudi Arabians. King Faisal Spec Hosp Med J 2:127–131

    Google Scholar 

  13. Sedrani SH, Elidrissy AW, El Arabi KM (1983) Sunlight and vitamin D status in normal Saudi subjects. Am J Clin Nutr 38(1):129–132

    CAS  PubMed  Google Scholar 

  14. Pietras SM, Obayan BK, Cai MH, Holick MF (2009) Vitamin D2 treatment for vitamin D deficiency and insufficiency for up to 6 years. Arch Intern Med 169(19):1806–1808

    Article  PubMed  Google Scholar 

  15. Sadat-Ali M, AlElq A, Al-Turki H, Al-Mulhim F, Al-Ali A (2009) Vitamin D levels in healthy men in eastern Saudi Arabia. Ann Saudi Med 29(5):378–382

    Article  PubMed Central  PubMed  Google Scholar 

  16. Elsammak MY, Al-Wossaibi AA, Al-Howeish A, Alsaeed J (2011) High prevalence of vitamin D deficiency in the sunny Eastern region of Saudi Arabia: a hospital-based study. East Mediterr Health J 17(4):317–322

    CAS  PubMed  Google Scholar 

  17. Ministry of Health, Oman. Muscat: Ministry of Health (2008) Micronutrients testing, community health and disease surveillance newsletter, pp 12–13

  18. Al-Kindi MK (2011) Vitamin D status in healthy Omani women of childbearing age: study of female staff at the Royal Hospital, Muscat, Oman. Sultan Qaboos Univ Med J 11(1):56–61

    PubMed Central  PubMed  Google Scholar 

  19. Al Kalbani M, Elshafie O, Rawahi M, Al-Mamari A, Al-Zakwani A, Woodhouse N (2011) Vitamin D Status in Pregnant Omanis: a disturbingly high proportion of patients with low vitamin D stores. Sultan Qaboos Univ Med J 11(1):52–55

    PubMed Central  PubMed  Google Scholar 

  20. Saadi HF, Dawodu A, Afandi BO, Zayed R, Benedict S, Nagelkerke N (2007) Efficacy of daily and monthly high-dose calciferol in vitamin D-deficient nulliparous and lactating women. Am J Clin Nutr 85(6):1565–1571

    CAS  PubMed  Google Scholar 

  21. Dawodu A, Kochiyil J, Altaye N (2011) Pilot study of sunlight exposure and vitamin D status in Arab women of childbearing age. East Mediterr Health J 17(7):570–574

    CAS  PubMed  Google Scholar 

  22. Al Anouti F, Thomas J, Abdel-Wareth L, Rajah J, Grant WB, Haq A (2011) Vitamin D deficiency and sun avoidance among university students at Abu Dhabi, United Arab Emirates. Dermatoendocrinol 3(4):235–239

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  23. Bener A, Al-Ali M, Hoffmann GF (2009) High prevalence of vitamin D deficiency in young children in a highly sunny humid country: a global health problem. Minerva Pediatr 61(1):15–22

    CAS  PubMed  Google Scholar 

  24. Mahdy S, Al-Emadi SA, Khanjar IA, Hammoudeh MM, Sarakbi HA, Siam AM, Abdelrahman MO (2010) Vitamin D status in health care professionals in Qatar. Saudi Med J 31(1):74–77

    PubMed  Google Scholar 

  25. Prentice A, Schoenmakers I, Jones KS, Jarjou LMA, Goldberg GR (2009) Vitamin D deficiency and its health consequences in Africa. Clinic Rev Bone Miner Metab 7:94–106

    Article  CAS  Google Scholar 

  26. Amr N, Hamid A, Sheta M, Elsedfy H (2012) Vitamin D status in healthy Egyptian adolescent girls. Georgian Med News 210:65–71

    PubMed  Google Scholar 

  27. Alagöl F, Shihadeh Y, Boztepe H, Tanakol R, Yarman S, Azizlerli H et al (2000) Sunlight exposure and vitamin D deficiency in Turkish women. J Endocrinol Investig 23(3):173–177

    Article  Google Scholar 

  28. Mishal AA (2001) Effects of different dress styles on vitamin D levels in healthy young Jordanian women. Arch Osteoporos 12:931–935

    Article  CAS  Google Scholar 

  29. O’Regan S, Chesney RW, Hamstra A, Eisman JA, O’ Gorman AM, Deluca HF (1979) Reduced serum 1,25-(OH)2 vitamin D3 levels in prednisone- treated adolescents with systemic lupus erythematosus. Acta Paediatr Scand 68:109–111

    Article  PubMed  Google Scholar 

  30. Chaiamnuay S, Chailurkit L, Narongroeknawin P, Asavatanabodee P, Laohajaroensombat S, Chaiamnuay P (2013) Current daily glucocorticoid use and serum creatinine levels are associated with lower 25(OH) vitamin D levels in Thai patients with systemic lupus erythematosus. JCR 19(3):121–125

    PubMed  Google Scholar 

  31. Huisman AM, White KP, Algra A, Harth M, Vieth R, Jacobs JW et al (2001) Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia. J Rheumatol 28:2535–2539

    CAS  PubMed  Google Scholar 

  32. Bultink IE, Lems WF, Kostense PJ, Dijkmans BA, Voskuyl AE (2005) Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus. Arthritis Rheum 52:2044–2050

    Article  PubMed  Google Scholar 

  33. Muller K, Kriegbaum NJ, Baslund B, Sørensen OH, Thymann M, Bentzen K (1995) Vitamin D3 metabolism in patients with rheumatic diseases: low serum levels of 25-hydroxyvitamin D3 in patients with systemic lupus erythematosus. Clin Rheumatol 14:397–400

    Article  CAS  PubMed  Google Scholar 

  34. Kamen DL, Cooper GS, Bouali H, Shaftman SR, Hollis BW, Gilkeson GS (2006) Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 5:114–117

    Article  CAS  PubMed  Google Scholar 

  35. Cutolo M, Otsa K (2008) Review: vitamin D, immunity and lupus. Lupus 17:6–10

    Article  CAS  PubMed  Google Scholar 

  36. Chen S, Sims GP, Chen XX, Gu YY, Lipsky PE (2007) Modulatory effects of 1, 25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 179:1634–1647

    Article  CAS  PubMed  Google Scholar 

  37. Orbach H, Zandman-Goddard G, Amital H, Barak V, Szekanecz Z, Szucs G et al (2007) Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases. Ann NY Acad Sci 1109:385–400

    Article  CAS  PubMed  Google Scholar 

  38. Ruiz-Irastorza G, Egurbide MV, Olivares N, Martinez-Berriotxoa A, Aguirre C (2008) Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences. Rheumatology (Oxford) 2047:920–923

    Article  Google Scholar 

  39. Abou-Raya A, Abou-Raya S, Helmii M (2013) The effect of vitamin D supplementation on inflammatory and hemostatic markers and disease activity in patients with systemic lupus erythematosus: a randomized placebo-controlled trial. J Rheumatol 40:265–272

    Article  CAS  PubMed  Google Scholar 

  40. Emerah A, El-Shal A (2013) Role of vitamin D receptor gene polymorphisms and serum 25-hydroxyvitamin D level in Egyptian female patients with systemic lupus erythematosus. Mol Biol Rep 40:6151–6162

    Article  CAS  PubMed  Google Scholar 

  41. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277

    Article  CAS  PubMed  Google Scholar 

  42. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI.A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum 35:630–640

    Article  CAS  PubMed  Google Scholar 

  43. Wielders JP, Wijnberg FA (2009) Preanalytical stability of 25(OH)—vitamin D3 in human blood or serum at room temperature: solid as a rock. Clin Chem 55(8):1584–1585

    Article  CAS  PubMed  Google Scholar 

  44. Alshishtawy MM (2012) Vitamin D Deficiency: this clandestine endemic disease is veiled no more. Sultan Qaboos Univ Med J 12(2):140–152

    Article  PubMed Central  PubMed  Google Scholar 

  45. Holick MF (2004) Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 79:362–371

    CAS  PubMed  Google Scholar 

  46. Cantorna MT, Mahon BD (2004) Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med (Maywood) 229:1136–1142

    CAS  Google Scholar 

  47. Casella CB, Seguro LP, Takayama L, Medeiros D, Bonfa E, Pereira RM (2012) Juvenile onset systemic lupus erythematosus: a possible role for vitamin D in disease status and bone health. Lupus 21(12):1335–1342

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

All authors have no conflict of interest in relation to the research topic, and the authors did not receive any funding concerning this research.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ayman El Garf.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Garf, K.E., Marzouk, H., Farag, Y. et al. Vitamin D status in Egyptian patients with juvenile-onset systemic lupus erythematosus. Rheumatol Int 35, 1535–1540 (2015). https://doi.org/10.1007/s00296-015-3245-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-015-3245-x

Keywords

Navigation